Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1642 |
|---|---|
| Identifier | NCT05104229 |
| Trial Title | SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Ulcerative Colitis|Venous Thromboembolism |
| Interventions | DRUG: Aspirin 81Mg Ec Tab|DRUG: Standard of Care |
Participant Information
| Sponsor | Stefan Holubar MD MS FACS, FASCRS |
|---|---|
| City | Cleveland |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2024-06-01 |
|---|---|
| Primary Completion Date | 2025-05-31 |
| Completion Date | 2026-01-01 |